LFST

LifeStance Health Group, Inc. (LFST)

Last Price$7.9(1.3%)
Market Cap$2,957.7M
LTM EPS
($0.3)
YoY Growth
-50.8%
3Y CAGR
-25.5%
5Y CAGR
N/A
Stock quality & Intrinsic value
5/10
45.6% overvalued

LifeStance Health Group, Inc. EPS

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'19Dec'20Dec'21Dec'22Dec'23
EPS
$0.0
($0.1)
($0.9)
($0.6)
($0.5)
LFST
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for LFST and see if it's the right time to invest.
Dive in

LifeStance Health Group, Inc. (LFST) EPS comparison analysis

Crunching data... Almost there!

LFST key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is LifeStance Health Group, Inc.'s EPS?

As of today, LifeStance Health Group, Inc.'s last 12-month EPS is ($0.3), based on the financial report for Sep 30, 2024 (Q3 2024).

2) What is LifeStance Health Group, Inc.'s EPS growth rate?

Over the last year, LifeStance Health Group, Inc.'s EPS growth was (50.8%). The average annual EPS growth rates for LifeStance Health Group, Inc. have been 60.3% over the past three years, N/A over the past five years.

3) Is LifeStance Health Group, Inc.'s EPS growth rate Good?

Over the last year, LifeStance Health Group, Inc.'s EPS growth was (50.8%), which is lower than industry growth of 0.6%. It indicates that LifeStance Health Group, Inc.'s EPS growth is Bad.

4) How does LifeStance Health Group, Inc.'s EPS growth rate compare to its peers?

Over the last year, LifeStance Health Group, Inc.'s EPS growth was (50.8%), which is lower than peer median growth of 41.3%. The list of peers includes THC, HCA, CHE, UHS, DVA, ENSG, EHC, ACHC, FMS, OPCH etc.